Benzinga | Jun 2, 2021 08:10AM EDT

Apollo Medical Holdings, Inc. Announces Purchase Of Controlling Interests In Sun Clinical Laboratories For $4M

Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:AMEH), a leading physician-centric, technology-powered healthcare company focused on value-based care, today announced that the Company has entered into a definitive agreement with Sun Clinical Laboratories ("Sun Labs"), under which ApolloMed will purchase controlling interests in Sun Labs for $4.0 million.